A carregar...
SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
At the end of 2019, the COVID-19 pandemic began, which at the time of writing continues to be a serious problem for many areas of medicine, including neurology. Since patients with multiple sclerosis (MS) often exhibit motor disability and receive disease-modifying therapy (DMT), which has an immuno...
Na minha lista:
| Publicado no: | Clin Neurol Neurosurg |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7831713/ https://ncbi.nlm.nih.gov/pubmed/33388661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clineuro.2020.106451 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|